Concepedia

Publication | Open Access

A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy

DOIFull Paper Access

38

Citations

11

References

2021

Year

Renuka Raman, Vijaykumar Bhagwan Barge, Darivenula Anil Kumar, Himanshu Dandu, R Rakesh Kartha, Varun Bafna, Vishaly T Aravinda, Thummala C Raghuram
The Journal of Infectious Diseases

Abstract

Intravenous immunoglobulin was safe and efficacious as an adjuvant with other antiviral drugs in the treatment of COVID-19.

References

YearCitations

Page 1